Clinical Trials in North Carolina

Showing 8261-8280 of 15,496 trials

Pre-medication With Alfentanil vs Placebo During ECT

NCT03359395

Hemodynamic changes associated with the conduct of electroconvulsive therapy may be minimized with the administration of alfentanil as part of their anesthetic regimen. This study proposes to compare the effects in a blinded fashion. Currently alfentanil is an FDA approved drug used on a daily basis by anesthesiologists on other surgeries so this is not a new indication.

Blood PressureElectroconvulsive Therapy

Wake Forest University Health Sciences100 participantsStarted Jun 2018

Winston-Salem, North Carolina, United States

COMPLETEDPhase 241 miles

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

NCT01777165

This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery.

Acute Kidney Injury

AbbVie240 participantsStarted Feb 2013

Danbury, Connecticut, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +38 more locations

Pre-medication With Alfentanil vs Placebo During ECT

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Find Trials by Condition in North Carolina

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Alglucosidase Alfa Pompe Safety Sub-Registry

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.

Long-term Effect of Lanthanum Carbonate on Bone

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

Dysport in Hallux Abducto Valgus (HAV) Phase IIa

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Long Term Study of Canakinumab (ACZ885) in Patients With Gout